Longitudinal Assessment of Atypical Tripeptidyl Peptidase 1 Enzyme Deficiency (Neuronal Ceroid Lipofuscinosis Type 2) Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04098211

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:00.410334+00:00

Published At

2026-04-08T00:00:00+00:00

Record Updated At

2026-04-08

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Neuronal Ceroid-Lipofuscinoses", "Neuronal Ceroid Lipofuscinosis CLN2", "Spinocerebellar Ataxia, Autosomal Recessive 7"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-04-08"

protocolSection.identificationModule.nctId

"NCT04098211"

protocolSection.identificationModule.officialTitle

"Longitudinal Assessment of Atypical Tripeptidyl Peptidase 1 Enzyme Deficiency (Neuronal Ceroid Lipofuscinosis Type 2) Patients"

protocolSection.statusModule.overallStatus

"ACTIVE_NOT_RECRUITING"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Neuronal Ceroid-Lipofuscinoses (protocolSection.conditionsModule.conditions)
• Neuronal Ceroid Lipofuscinosis CLN2 (protocolSection.conditionsModule.conditions)
• Spinocerebellar Ataxia, Autosomal Recessive 7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.